Stem cell therapy Market: Segmented: By Type (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Embryonic Stem Cells and Others); By Technology (Cell Acquisition, Cell Production and Cryopreservation); By Application (Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases and Others), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
[ 170 + Pages Research Report ]Stem cell therapy Market to surpass USD 27.94 billion by 2031 from USD 11.43 billion in 2021 at a CAGR of 13.4% in the coming years, i.e., 2021-31.
Product Overview
Stem cells, which can proliferate and develop into almost any cell type in the body, are used in surgery and medicine. The stem cell is the source of all cells in the human body. It can replicate itself as well as heal and replace damaged tissues in the human body. Stem cell therapy is a relatively simple procedure that avoids the risks associated with invasive surgical procedures. Furthermore, stem cell therapy uses cells derived from the patient's own body, lowering the risk of immunological rejection. Stem cell therapy is also referred to as regenerative medicine or focal point therapy. Stem cell therapies are also used to treat a variety of chronic illnesses, such as cancer and blood disorders.
Market Highlights
The global Stem cell therapy market is expected to project a notable CAGR of 13.4% in 2031.
Rising stem cell research activities and increasing approvals of GMP-certified facilities to manufacture stem cells are driving the market growth. The growing demand for iPSCs as an alternative to ESCs, as well as the growing demand for cell and gene therapies, are expected to drive market growth in the coming years.
Global Stem cell therapy Market: Segments
Adipose Tissue-Derived Mesenchymal Stem Cells segment to grow with the highest CAGR during 2021-31
Based on type, the global Stem cell therapy Market is fragmented into Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Embryonic Stem Cells, and Others. Because of their growing use in treating inflammatory illnesses, wounds, and traumas, adipose tissue-derived mesenchymal stem cells are expected to dominate the global market during the forecasted period. Furthermore, the numerous benefits of using adipose tissue-derived stem cells, such as the ease of harvesting stem cells using minimally invasive techniques, the simplicity of the isolation approach, and the higher quality and proliferation capacity of the stem cells, will drive the segment even further.
Cell Acquisition segment to grow with the highest CAGR during 2021-31
The global Stem cell therapy market is classified based on category into Cell Acquisition, Cell Production, and Cryopreservation. Cell acquisition held the largest CAGR over the forecast period due to rising research studies involving cell harvesting.
Musculoskeletal Disorders segment to grow with the highest CAGR during 2021-31
Based on application, the global Stem cell therapy Market is fragmented into Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others. Because of the rising incidence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration, the musculoskeletal disorders segment is expected to dominate the global market during the forecasted period. Furthermore, several governments are heavily investing in the development of regenerative medicines. The medications created will aid in the treatment of a variety of heart diseases, blood disorders, vision loss, and diabetes.
Market Dynamics
Drivers
Increasing use in oncology and regenerative medicine
The use of stem cells in regenerative medicine, particularly in dermatology, is expected to drive significant growth in the global Stem Cell Therapy Market during the forecasted period. Furthermore, rising oncology use, as a result of a large number of pipeline medicines in development for the treatment of tumors or malignancies, would propel the market forward. Furthermore, the rising prevalence of chronic diseases has aided the growth of the stem cell treatment industry.
Increased investments in R&D and emphasis on personalized medicine
Increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing emphasis on the development of personalized medicines are all factors driving growth. The growing emphasis on the treatment of neurological disorders contributes to market growth. Furthermore, the growing popularity of personalized medicines is fueling market growth. Researchers are developing new procurement methods that can be used to develop personalized medicines. Furthermore, companies are focusing on developing therapies to alleviate the various stressors associated with COVID-19, which is increasing demand.
Restraint
Ethical concerns and high costs associated with the market
High costs associated with the stem cell market and the lack of a well-defined framework are expected to hamper the market growth. Also, because stem cells are derived by destroying the human embryo, they raise several ethical concerns. Human embryos are regarded as potential life, and destroying them is considered unethical. Concerns about the use of embryonic stem cells in the development of stem cell therapy are limiting the global market growth.
Global Stem cell therapy Market: Key Players
Osiris
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Lineage Cell Therapeutics, Inc.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Astellas Pharma Inc.
Athersys, Inc.,
Cytori Therapeutics Inc.
Fate Therapeutics
ReNeuron Group plc
Other Prominent Players
Global Stem cell therapy Market: Regions
The global Stem cell therapy market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and strong reimbursement policies all contribute to the North American region's growth. Because of the increasing development of stem cell-based therapies, government initiatives for developing regenerative medicines, the establishment of several stem cell banks, and the expansion of clinical trials for regenerative medicines, the region is expected to grow.
The global Stem cell therapy market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
the Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
The global Stem cell therapy Market report also contains an analysis on:
Stem cell therapy Market Segments:
By Type
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Embryonic Stem Cells
Others
By Technology
Cell Acquisition
Cell Production
Cryopreservation
By Application
Musculoskeletal Disorders
Wounds and Injuries
Cardiovascular Diseases
Surgeries
Gastrointestinal Diseases
Others
Stem cell therapy Market Dynamics
Stem cell therapy Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Stem cell therapy Market Report Scope and Segmentation
Report Attribute
Details
The market size value in 2021 USD 11.43 billion
The revenue forecast in 2031 USD 27.94 billion
Growth Rate CAGR of 13.4% from 2021 to 2031
The base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, Technology, Application, and Region
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Osiris, Lineage Cell Therapeutics, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Astellas Pharma Inc., Athersys, Inc., Cytori Therapeutics Inc., Fate Therapeutics, ReNeuron Group plc. and Other Prominent Players
Product Overview
Stem cells, which can proliferate and develop into almost any cell type in the body, are used in surgery and medicine. The stem cell is the source of all cells in the human body. It can replicate itself as well as heal and replace damaged tissues in the human body. Stem cell therapy is a relatively simple procedure that avoids the risks associated with invasive surgical procedures. Furthermore, stem cell therapy uses cells derived from the patient's own body, lowering the risk of immunological rejection. Stem cell therapy is also referred to as regenerative medicine or focal point therapy. Stem cell therapies are also used to treat a variety of chronic illnesses, such as cancer and blood disorders.
Market Highlights
The global Stem cell therapy market is expected to project a notable CAGR of 13.4% in 2031.
Rising stem cell research activities and increasing approvals of GMP-certified facilities to manufacture stem cells are driving the market growth. The growing demand for iPSCs as an alternative to ESCs, as well as the growing demand for cell and gene therapies, are expected to drive market growth in the coming years.
Global Stem cell therapy Market: Segments
Adipose Tissue-Derived Mesenchymal Stem Cells segment to grow with the highest CAGR during 2021-31
Based on type, the global Stem cell therapy Market is fragmented into Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Embryonic Stem Cells, and Others. Because of their growing use in treating inflammatory illnesses, wounds, and traumas, adipose tissue-derived mesenchymal stem cells are expected to dominate the global market during the forecasted period. Furthermore, the numerous benefits of using adipose tissue-derived stem cells, such as the ease of harvesting stem cells using minimally invasive techniques, the simplicity of the isolation approach, and the higher quality and proliferation capacity of the stem cells, will drive the segment even further.
Cell Acquisition segment to grow with the highest CAGR during 2021-31
The global Stem cell therapy market is classified based on category into Cell Acquisition, Cell Production, and Cryopreservation. Cell acquisition held the largest CAGR over the forecast period due to rising research studies involving cell harvesting.
Musculoskeletal Disorders segment to grow with the highest CAGR during 2021-31
Based on application, the global Stem cell therapy Market is fragmented into Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others. Because of the rising incidence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration, the musculoskeletal disorders segment is expected to dominate the global market during the forecasted period. Furthermore, several governments are heavily investing in the development of regenerative medicines. The medications created will aid in the treatment of a variety of heart diseases, blood disorders, vision loss, and diabetes.
Market Dynamics
Drivers
Increasing use in oncology and regenerative medicine
The use of stem cells in regenerative medicine, particularly in dermatology, is expected to drive significant growth in the global Stem Cell Therapy Market during the forecasted period. Furthermore, rising oncology use, as a result of a large number of pipeline medicines in development for the treatment of tumors or malignancies, would propel the market forward. Furthermore, the rising prevalence of chronic diseases has aided the growth of the stem cell treatment industry.
Increased investments in R&D and emphasis on personalized medicine
Increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing emphasis on the development of personalized medicines are all factors driving growth. The growing emphasis on the treatment of neurological disorders contributes to market growth. Furthermore, the growing popularity of personalized medicines is fueling market growth. Researchers are developing new procurement methods that can be used to develop personalized medicines. Furthermore, companies are focusing on developing therapies to alleviate the various stressors associated with COVID-19, which is increasing demand.
Restraint
Ethical concerns and high costs associated with the market
High costs associated with the stem cell market and the lack of a well-defined framework are expected to hamper the market growth. Also, because stem cells are derived by destroying the human embryo, they raise several ethical concerns. Human embryos are regarded as potential life, and destroying them is considered unethical. Concerns about the use of embryonic stem cells in the development of stem cell therapy are limiting the global market growth.
Global Stem cell therapy Market: Key Players
Osiris
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Lineage Cell Therapeutics, Inc.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Astellas Pharma Inc.
Athersys, Inc.,
Cytori Therapeutics Inc.
Fate Therapeutics
ReNeuron Group plc
Other Prominent Players
Global Stem cell therapy Market: Regions
The global Stem cell therapy market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and strong reimbursement policies all contribute to the North American region's growth. Because of the increasing development of stem cell-based therapies, government initiatives for developing regenerative medicines, the establishment of several stem cell banks, and the expansion of clinical trials for regenerative medicines, the region is expected to grow.
The global Stem cell therapy market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
the Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
The global Stem cell therapy Market report also contains an analysis on:
Stem cell therapy Market Segments:
By Type
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Embryonic Stem Cells
Others
By Technology
Cell Acquisition
Cell Production
Cryopreservation
By Application
Musculoskeletal Disorders
Wounds and Injuries
Cardiovascular Diseases
Surgeries
Gastrointestinal Diseases
Others
Stem cell therapy Market Dynamics
Stem cell therapy Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Stem cell therapy Market Report Scope and Segmentation
Report Attribute
Details
The market size value in 2021 USD 11.43 billion
The revenue forecast in 2031 USD 27.94 billion
Growth Rate CAGR of 13.4% from 2021 to 2031
The base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, Technology, Application, and Region
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Osiris, Lineage Cell Therapeutics, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Astellas Pharma Inc., Athersys, Inc., Cytori Therapeutics Inc., Fate Therapeutics, ReNeuron Group plc. and Other Prominent Players
1. EXECUTIVE SUMMARY
2. GLOBAL STEM CELL THERAPY MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL STEM CELL THERAPY MARKET ANALYSIS
10.1. Porter Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL STEM CELL THERAPY MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. GLOBAL STEM CELL THERAPY MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. Adipose Tissue-Derived Mesenchymal Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Bone Marrow-Derived Mesenchymal Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Embryonic Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.4. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. BY TECHNOLOGY: MARKET SHARE (2020-2031F)
13.1. Cell Acquisition, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13.2. Cell Production, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13.3. Cryopreservation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
14. BY APPLICATION: MARKET SHARE (2020-2031F)
15. MUSCULOSKELETAL DISORDERS, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
16. WOUNDS AND INJURIES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
17. CARDIOVASCULAR DISEASES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
18. SURGERIES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
19. GASTROINTESTINAL DISEASES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
19.1. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
20. COMPANY PROFILE
20.1. Osiris
20.1.1. Company Overview
20.1.2. Company Total Revenue (Financials)
20.1.3. Market Potential
20.1.4. Global Presence
20.1.5. Key Performance Indicators
20.1.6. SWOT Analysis
20.1.7. Product Launch
20.2. Lineage Cell Therapeutics, Inc.
20.3. Takara Bio Inc.
20.4. Thermo Fisher Scientific Inc.
20.5. Astellas Pharma Inc.
20.6. Athersys, Inc.,
20.7. Cytori Therapeutics Inc.
20.8. Fate Therapeutics
20.9. ReNeuron Group plc
20.10. Other Prominent Players
21. CONSULTANT RECOMMENDATION
21.1.1. The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL STEM CELL THERAPY MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL STEM CELL THERAPY MARKET ANALYSIS
10.1. Porter Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL STEM CELL THERAPY MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. GLOBAL STEM CELL THERAPY MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. Adipose Tissue-Derived Mesenchymal Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Bone Marrow-Derived Mesenchymal Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Embryonic Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.4. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. BY TECHNOLOGY: MARKET SHARE (2020-2031F)
13.1. Cell Acquisition, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13.2. Cell Production, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13.3. Cryopreservation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
14. BY APPLICATION: MARKET SHARE (2020-2031F)
15. MUSCULOSKELETAL DISORDERS, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
16. WOUNDS AND INJURIES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
17. CARDIOVASCULAR DISEASES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
18. SURGERIES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
19. GASTROINTESTINAL DISEASES, BY VALUE (USD MILLION) 2020-2031F; Y-O-Y GROWTH (%) 2021-2031F
19.1. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
20. COMPANY PROFILE
20.1. Osiris
20.1.1. Company Overview
20.1.2. Company Total Revenue (Financials)
20.1.3. Market Potential
20.1.4. Global Presence
20.1.5. Key Performance Indicators
20.1.6. SWOT Analysis
20.1.7. Product Launch
20.2. Lineage Cell Therapeutics, Inc.
20.3. Takara Bio Inc.
20.4. Thermo Fisher Scientific Inc.
20.5. Astellas Pharma Inc.
20.6. Athersys, Inc.,
20.7. Cytori Therapeutics Inc.
20.8. Fate Therapeutics
20.9. ReNeuron Group plc
20.10. Other Prominent Players
21. CONSULTANT RECOMMENDATION
21.1.1. The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
